The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

News

Every story, newest first.

Laws · District of Columbia · November 16, 2026

Cannabis Regulatory Confusion and Its Impact on Consumer Adoption. – EBSCO

A study in the American Business Law Journal examines cannabis regulatory confusion and how it shapes consumer adoption. Authors Stephanie Geiger-Oneto and Robert Sprague say U.S. rules are inconsistent: marijuana stays Schedule I federally, yet eleven states and D.C. had legalized recreational use and thirty-six states and D.C. allowed medical use by the end of 2020.

Why it matters: The research suggests mixed legal signals do more than confuse; they may keep cannabis a stigmatized product even as legal access grows. For consumers and patients, that means the federal-state conflict can shape how legitimate the products seem, and how comfortable people feel buying them, not just whether purchases are legal.

Read moreSource: ebsco.com

Laws · Massachusetts · November 16, 2026

Lowell rejects cannabis consumption lounge plan

Lowell's City Council voted 7-3 against a motion asking the city manager for a report on cannabis consumption lounges. Councilor Corey Robinson sought the study, including zoning considerations, and softened it from a detailed plan to a report. Several colleagues still objected, citing impaired driving, potency and concentration of businesses in the Acre neighborhood.

Why it matters: Massachusetts now has rules for cannabis lounges, but they only open where a community opts in. Lowell's vote means local consumers there gain no path toward a legal place to use cannabis socially anytime soon. Patchy local decisions will keep deciding where lounges appear, with Haverhill ahead and Lowell holding back.

Read moreSource: lowellsun.com

Laws · Iowa · November 16, 2026

Iowa Board Recommends Ending Medical Cannabis Sales Tax

Iowa's Medical Cannabidiol Board voted November 6 to recommend ending sales tax on medical cannabis, part of seven unanimously approved proposals. Iowa Health and Human Services spokeswoman Danielle Sample confirmed the list. The board only advises, so the medical cannabis sales tax stays in place until lawmakers change Iowa law.

Why it matters: For Iowa patients, the vote signals a possible cut to checkout costs, but nothing changes today. Tax is only one expense beside the product price and the yearly card fee. The board also reaffirmed its opposition to raw flower, so product choices are not expected to widen. Lawmakers must act first.

Read moreSource: cannabisaficionado.com

Products · Michigan · November 16, 2026

The full Metro Times Cannabis Week lineup is here

Metro Times has finalized the lineup for its first Metro Times Cannabis Week, running Nov. 16-22. Twelve more Michigan brands join seven announced earlier, including The Hive, Growing Pains, DogHouse Farms and Seed Junky. Sponsors Puff Cannabis and BDT Smoke Shop are also offering deals, with participating discounts reaching 50%.

Why it matters: For Michigan buyers, the week means a concentrated stretch of markdowns on flower, rosin, edibles and unusual formats like lip pouches. Discounts of up to 50% suggest brands are competing hard on price. Shoppers can compare products through a sign-up site that maps participating dispensaries, though deals vary by brand and store.

Read moreSource: metrotimes.com

Profiles · California · November 16, 2026

Glass House Is Down 90% Since Its NYSE Debut. The Questions Are Piling Up

Glass House Brands stock plunge continues after the California cannabis grower said it pushed out new auditor BDO and brought back MGO. Shares fell over 33% Thursday to about $1.25, then edged up to $1.29 Friday, still roughly 90% below the June 30 NYSE debut. BDO called its review of the deal behind the listing an unresolved issue.

Why it matters: Glass House and Trulieve showed that cannabis firms can reach the NYSE only by splitting off recreational operations, and the early results are poor. For consumers, that signals that investor money is waiting on federal rules covering adult-use cannabis, so company stability and funding for brands you buy may stay uncertain for now.

Read moreSource: finance.yahoo.com

Products · Florida · November 16, 2026

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

Trulieve is opening a new Tampa medical cannabis dispensary in Hillsborough County, Florida. Trulieve Tampa Hillsborough West, at 13829 W. Hillsborough Ave., will hold a grand opening Friday, November 20, with specials, discounts and giveaways. It offers walk-in and express pickup, and will stock Trulieve's own brands plus partner labels sold exclusively through the company in Florida.

Why it matters: For Florida patients in the Tampa area, this adds another storefront with walk-in and express pickup options, plus brands Trulieve says are available only through its Florida stores. The opening-week discounts and the company's stated 60% first-time and 20% veteran discounts could lower costs for some registered patients. Access remains tied to medical registration.

Read moreSource: PR Newswire

The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Medical · November 16, 2026

Boots to sell medicinal cannabis – Yahoo

Boots will begin offering medicinal cannabis through a private online service called SureLeaf, making it the first UK high street pharmacy chain to do so. Patients aged 25 and over can be prescribed it for conditions such as chronic pain, anxiety or insomnia after an online assessment and a video consultation with a doctor.

Why it matters: Medicinal cannabis in Britain has been hard to get through the NHS, which prescribes it rarely. A big pharmacy brand entering the private market could make access easier for people with chronic pain who can afford it. The service sets conditions, though: patients must first have tried conventional medicines, and regular reviews follow. Official NHS guidance still advises against routine use for chronic pain.

Read moreSource: yahoo.com

Medical · Illinois · November 16, 2026

Illinois cannabis use has climbed since legalization | The 21st Show

Illinois cannabis use has climbed since recreational sales began nearly seven years ago, according to the 2026 report from the Illinois Cannabis Project at UIC. About 25% of residents 12 and older used in the past year, versus roughly 15% before, and daily use nearly doubled to about 9%. Youth use fell, and use among adults with severe mental illness jumped.

Why it matters: The numbers give Illinois lawmakers and regulators data on who is using more, and the mental illness finding is the sharpest flag. Past-year use in that group rose from 34% to 59%. Patients and consumers may see that fuel debate over screening, labeling and medical oversight, while the drop in youth use gives legalization supporters evidence to cite.

Read moreSource: will.illinois.edu

Laws · Wisconsin · November 16, 2026

Hesselbein, Neubauer on ‘UpFront’ promise ambitious agenda – State Affairs Pro

Wisconsin Democrats who take control of the Legislature in January say legalizing marijuana is a top priority. Incoming Senate Majority Leader Dianne Hesselbein and Assembly Speaker Greta Neubauer said Wisconsin marijuana legalization could help fund the budget. Republican Rep. Tyler August suggested starting with medical cannabis and was unsure any Republicans would back full legalization.

Why it matters: Democrats gaining both chambers for the first time in 16 years puts legalization on the agenda, but nothing is decided. Republicans have signaled that a medical-only program may be the more workable first step. For Wisconsin consumers and patients, the path to legal access remains uncertain and could land narrower than full adult use.

Read moreSource: pro.stateaffairs.com

Medical · November 16, 2026

Cannabis Legalization Linked to More Heart-Related Hospitalizations

A new study ties cannabis legalization to more heart-related hospital stays. Researchers at Boston University's medical school, publishing in BMJ Open, studied over 50 million hospitalizations and compared Western US regions that legalized early with regions that had not. Each legal year was linked to higher rates of atrial fibrillation, heart failure and heart attack.

Why it matters: The findings point to a possible public health cost of legalization showing up in hospital data, not just in cannabis-related diagnoses. The study shows association, not proof of cause, and it does not say who is at risk. Still, consumers and patients with heart conditions may see the topic gain attention from doctors and policymakers.

Read moreSource: ophthalmologyadvisor.com